Advertisement
U.S. Markets closed

Defence Therapeutics Inc. (DTC.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
0.5500-0.0100 (-1.79%)
At close: 12:15PM EDT
Full screen
Previous Close0.5600
Open0.0000
Bid0.5600 x N/A
Ask0.6200 x N/A
Day's Range0.5600 - 0.5600
52 Week Range0.4800 - 2.9000
Volume0
Avg. Volume28,009
Market Cap25.045M
Beta (5Y Monthly)1.45
PE Ratio (TTM)N/A
EPS (TTM)-0.3000
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Newsfile

    Defence Therapeutics Completes 1st Tranche of Financing

    Vancouver, British Columbia--(Newsfile Corp. - October 30, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing radiopharmaceuticals and novel immune-oncology vaccines and drug delivery technologies, is pleased to announce the closing of the 1st tranche of its previously announced non-brokered private placement (the "Offering") of units of the Company (the "Units") at a price of $0.50 per Unit for agg

  • Newsfile

    Defence's Corporate Updates, Arranges Financing

    Vancouver, British Columbia--(Newsfile Corp. - September 27, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a Canadian biopharmaceutical company developing radiopharmaceuticals and novel immune-oncology vaccines and drug delivery technologies, is pleased to give a corporate update and to announce a financing.The Company wishes to announce that Mr. Sebastien Plouffe, Defence's Founder and Director, is stepping back-in as the Chief Executive Of